Skip to main content
INBX logo

INBX · Inhibrx Biosciences, Inc. · Holdings

Track INBX — free
$92.76 -0.60 (-0.64%) At close · Oct 8
Market Cap
$1.37B
Shares
14.72M
Volume · Oct 8 208.06K Avg daily vol (3M) 295.27K

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Some SEC filings for this period have not finished importing. Holder totals and changes may be incomplete; these filings remain queued for recovery.
The Sep 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out. Each fund's Change is measured against its own previous reported quarter, shown in the Reported column. Pick a completed quarter in the Quarter selector below to put every fund on one quarter and see the stock-wide activity breakdown.
Holders: 165
Total Value: $1,393,600,423
Total Shares: 14,707,901
Showing 1–100 of 175 holdings by value · page 1 of 2

Institutional Ownership Trend

10 quarters

Holder Concentration

Across 166 13F filers
Top Holder
8.9%
Jun 2024 → Jun 2026 · range 8.9% – 19.4%
of institutional value
Top 5
39.2%
Jun 2024 → Jun 2026 · range 39.2% – 55.1%
of institutional value
Top 10
62.9%
Jun 2024 → Jun 2026 · range 62.0% – 76.8%
of institutional value
HHI
479
Jun 2024 → Jun 2026 · range 479 – 786
Broadly held
Showing 100 of 175
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 2007919 CUSIP 45720N103 13F (30d) 4 filings 4 filers Visit website Investor relations